Medial EarlySign Ltd.

earlysign.com

Formerly MCS Medial Cancer Screening

High-Tech Company

Ceased to Operate Q2/2025

TECH VERTICALS

Artificial Intelligence, Big Data, Diagnostics, Digital Health, Disease Management, Healthtech, Life Sciences, Machine Learning, MedTech

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2012
Number of Employees	20
Employees in Israel	16
Reg. Number:	abCDe

DESCRIPTION

Medial EarlySign is an operator of an AI-based algorithm platform, intended to improve patient and non-communicable disease management. The company's platform stratifies populations to optimize care for individuals and prevent or delay serious health conditions by leveraging routine blood test results and common labs and EHR data, enabling healthcare organizations to improve patient outcomes, focus financial resources and reduce overall costs.

TECHNOLOGY

Medial's algorithms are supposed to help doctors locate patients in a risk group and call them for CT scans to detect tumors, while surgery to remove them is still possible. The company's algorithms help identify at-risk groups that do not necessarily cooperate with the routine tests.

Products and Phases

Product	Phase
ColonFlag	CE Approved
ColonFlag picks up on hidden signals in routine blood tests and flags high risk individuals. By alerting the physicians of those individuals and encouraging them to send their patients to an immediate evaluation (e.g. colonoscopy), CRC can be found and treated earlier.
AlgoAnalyzer	Phase I
AlgoAnalyzer is an operating system, which serves as a hosting environment for various healthcare calculators. AlgoAnalyzer is integrated into healthcare IT environments and facilitates the extraction and communication of EHR and lab data. The operating system blends into healthcare professionals’ existing workflows, creating a seamless integration process of the predictors into their patient care routines.
AlgoMarker	Phase I
AlgoMarkers is an app-like Artificial intelligence clinical risk predictor that supports a healthcare organization’s care needs.

	TARGET MARKETS
	Oncologists, Doctors and their patients, Hospitals, Healthcare providers & organizations.

	BUSINESS MODEL
	B2B

COMPETITORS

InsightRX , Infermedica , Prognos

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Medial Research Ltd.
19B27307-52FC-E311-B941-80C16E7D3630	Subsidiary	Medial EarlySign Ltd.	Medial Research Ltd.	Ceased

CONTACT INFO

Expand / Collapse All

Main Address: Hod Hasharon, Israel

Address	6 Hanagar St., Suite 300
POB	300
City	Hod Hasharon
Country	Israel
Zip	4527703

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Munster, Germany

Address	10 Borkstrabe
City	Munster
Country	Germany
Zip	48163

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Aurora, United States

Address	6105 S. Main St., Suite 200
City	Aurora
State/Province	CO
Country	United States
Zip	80016

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Offer Fabian	Co-Founder	InSightec (VP, Commercial Development)
Mr. Ofer Ariely	Co-Founder
Mr. Ori Geva	Co-Founder	Pontis (VP, Strategic Solutions)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Chairman, Expand Investments
abC Defghij	Board Member	N\A
abC Defghij	Board Member	Investor at Horizons Ventures
abC Defghij	Board Member	CEO & Co-Founder, Medial Earlysign
abC Defghij	Board Member	Anchor Investor & Co-Founder, aMoon Fund
abC Defghij	Board Member	Managing Partner & Co-Founder, aMoon

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round

Mar. 06, 2018

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

First Round

Jan. 01, 2016

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Private Investor	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jul. 14, 2021

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe